MTD

MKT CAP:$26B

Mettler-Toledo International Inc.

Market Cap

$26B

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$1,277.80-$133.59 (-9.46%)

Apr 24, 2026

Company Details

Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and O...

CEO

Patrick K. Kaltenbach

IPO Date

Nov 14, 1997

Website

www.mt.com

Key Metrics TTM

Revenue

$4.0B

+4.0% YoY

Net Income

$869M

EPS (Diluted)

$42.20

Free Cash Flow

$849M

Revenue / Share

$197.56

Gross Margin

57.5%

Operating Margin

27.8%

Net Margin

21.6%

FCF Margin

21.1%

P/S

6.5x

P/E

30.2x

Earnings Reports

Q1 2026

May 7, 2026

PENDING

FY 2025

Feb 6, 2026

$4.0B+4.0%EPS $42.17

Q4 2025

Feb 6, 2026

$1.1B+8.1%EPS $14.02

Q3 2025

Nov 7, 2025

$1.0B+7.9%EPS $10.57

Q2 2025

Aug 1, 2025

$983M+3.9%EPS $9.77

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$898M	$503M	$225M
Q2 22	$978M	$555M	$269M
Q3 22	$986M	$568M	$290M
Q4 22	$1.1B	$616M	$342M
Q1 23	$929M	$529M	$249M
Q2 23	$982M	$566M	$290M
Q3 23	$942M	$541M	$278M
Q4 23	$935M	$534M	$264M
Q1 24	$926M	$530M	$249M
Q2 24	$947M	$547M	$266M
Q3 24	$955M	$554M	$278M
Q4 24	$1.0B	$621M	$334M
Q1 25	$884M	$509M	$220M
Q2 25	$983M	$562M	$266M
Q3 25	$1.0B	$589M	$290M
Q4 25	$1.1B	$656M	$343M

Valuation

Quarter	P/S	P/E
Q1 22	8.3x	40.1x
Q2 22	6.7x	31.5x
Q3 22	6.5x	30.1x
Q4 22	8.2x	36.9x
Q1 23	8.5x	37.9x
Q2 23	7.2x	32.1x
Q3 23	6.0x	27.0x
Q4 23	6.6x	31.7x
Q1 24	7.5x	36.7x
Q2 24	7.8x	37.0x
Q3 24	8.4x	39.6x
Q4 24	6.6x	29.7x
Q1 25	6.4x	28.9x
Q2 25	6.3x	29.4x
Q3 25	6.3x	29.6x
Q4 25	7.3x	33.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$91M	$72M
Q2 22	$219M	$176M
Q3 22	$245M	$219M
Q4 22	$304M	$272M
Q1 23	$153M	$130M
Q2 23	$267M	$238M
Q3 23	$264M	$243M
Q4 23	$282M	$249M
Q1 24	$190M	$173M
Q2 24	$258M	$234M
Q3 24	$255M	$233M
Q4 24	$266M	$225M
Q1 25	$194M	$177M
Q2 25	$236M	$212M
Q3 25	$299M	$275M
Q4 25	$226M	$184M

Capital Expenditures

Quarter	CapEx
Q1 22	$19M
Q2 22	$43M
Q3 22	$27M
Q4 22	$32M
Q1 23	$23M
Q2 23	$29M
Q3 23	$21M
Q4 23	$32M
Q1 24	$17M
Q2 24	$24M
Q3 24	$21M
Q4 24	$41M
Q1 25	$17M
Q2 25	$24M
Q3 25	$24M
Q4 25	$42M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+11.6%	+10.8%
Q2 22	+5.8%	+3.5%
Q3 22	+3.6%	+0.0%
Q4 22	+2.0%	-2.7%
Q1 23	+3.4%	+1.0%
Q2 23	+0.4%	-2.4%
Q3 23	-4.4%	-4.4%
Q4 23	-11.6%	-6.2%
Q1 24	-0.3%	-0.5%
Q2 24	-3.6%	-1.7%
Q3 24	+1.3%	+1.7%
Q4 24	+11.8%	+6.0%
Q1 25	-4.6%	-1.9%
Q2 25	+3.9%	+5.4%
Q3 25	+7.9%	+9.4%
Q4 25	+8.1%	+10.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$5M	0.5%
Q2 22	$5M	0.5%
Q3 22	$5M	0.5%
Q4 22	$6M	0.5%
Q1 23	$4M	0.4%
Q2 23	$4M	0.4%
Q3 23	$4M	0.4%
Q4 23	$5M	0.6%
Q1 24	$5M	0.5%
Q2 24	$5M	0.5%
Q3 24	$4M	0.5%
Q4 24	$6M	0.6%
Q1 25	$5M	0.6%
Q2 25	$5M	0.5%
Q3 25	$6M	0.5%
Q4 25	$6M	0.6%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 22	$43M	$235M
Q2 22	$44M	$242M
Q3 22	$44M	$233M
Q4 22	$46M	$228M
Q1 23	$45M	$235M
Q2 23	$47M	$229M
Q3 23	$46M	$217M
Q4 23	$46M	$223M
Q1 24	$46M	$234M
Q2 24	$46M	$236M
Q3 24	$47M	$229M
Q4 24	$50M	$237M
Q1 25	$46M	$243M
Q2 25	$49M	$247M
Q3 25	$51M	$248M
Q4 25	$53M	$260M

Revenue Segments

Quarter	Industrial products and services	Laboratory products and services	Retail products and services
Q1 22	$344M	$514M	$41M
Q2 22	$384M	$546M	$48M
Q3 22	$387M	$555M	$44M
Q4 22	$396M	$616M	$46M
Q1 23	$355M	$520M	$54M
Q2 23	$399M	$527M	$56M
Q3 23	$366M	$509M	$68M
Q4 23	$370M	$513M	$51M
Q1 24	$352M	$525M	$49M
Q2 24	$374M	$523M	$49M
Q3 24	$366M	$535M	$54M
Q4 24	$398M	$603M	$44M
Q1 25	$341M	$500M	$42M
Q2 25	$395M	$538M	$51M
Q3 25	$406M	$565M	$59M
Q4 25	$437M	$638M	$54M

Revenue by Geography

Quarter	Americas	Asia	Europe
Q1 22	$353M	$295M	$250M
Q2 22	$394M	$342M	$243M
Q3 22	$408M	$349M	$228M
Q4 22	$428M	$336M	$294M
Q1 23	$372M	$303M	$254M
Q2 23	$397M	$339M	$246M
Q3 23	$398M	$290M	$255M
Q4 23	$402M	$273M	$260M
Q1 24	$384M	$268M	$274M
Q2 24	$404M	$284M	$259M
Q3 24	$394M	$301M	$260M
Q4 24	$424M	$313M	$308M
Q1 25	$378M	$258M	$248M
Q2 25	$414M	$295M	$274M
Q3 25	$432M	$305M	$293M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$117M	$0	$117M
Q2 22	$109M	$0	$109M
Q3 22	$122M	$0	$122M
Q4 22	$96M	$0	$96M
Q1 23	$89M	$0	$89M
Q2 23	$84M	$0	$84M
Q3 23	$70M	$0	$70M
Q4 23	$70M	$0	$70M
Q1 24	$70M	$0	$70M
Q2 24	$71M	$0	$71M
Q3 24	$72M	$0	$72M
Q4 24	$59M	$0	$59M
Q1 25	$64M	$0	$64M
Q2 25	$62M	$0	$62M
Q3 25	$69M	$0	$69M
Q4 25	$67M	$0	$67M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	23M	-0.8%	-2.7%
Q2 22	23M	-0.9%	-3.0%
Q3 22	23M	-0.9%	-3.3%
Q4 22	22M	-0.9%	-3.5%
Q1 23	22M	-0.7%	-3.4%
Q2 23	22M	-0.8%	-3.2%
Q3 23	22M	-0.9%	-3.2%
Q4 23	22M	-0.9%	-3.2%
Q1 24	22M	-0.7%	-3.2%
Q2 24	21M	-0.7%	-3.1%
Q3 24	21M	-0.5%	-2.7%
Q4 24	21M	-0.9%	-2.7%
Q1 25	21M	-1.1%	-3.1%
Q2 25	21M	-0.4%	-2.9%
Q3 25	21M	-1.0%	-3.4%
Q4 25	20M	-0.9%	-3.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$104.4K	9K
Q2 22	$113.8K	9K
Q3 22	$114.6K	9K
Q4 22	$116.2K	9K
Q1 23	$102.1K	9K
Q2 23	$107.9K	9K
Q3 23	$103.6K	9K
Q4 23	$54.0K	17K
Q1 24	$53.5K	17K
Q2 24	$54.7K	17K
Q3 24	$55.2K	17K
Q4 24	$60.4K	17K
Q1 25	$51.1K	17K
Q2 25	$56.8K	17K
Q3 25	$59.5K	17K
Q4 25	$121.5K	9K

Revenue / Employee